In vitro effects of peimine on the activity of cytochrome P450 enzymes.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1202, doi. 10.1080/00498254.2020.1761572
- By:
- Publication type:
- Article
Works in Xenobiotica, 2020, Vol 50, Issue 10
Results: 14
1
2
The use of inactivated brain homogenate to determine the in vitro fraction unbound in brain for unstable compounds.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1228, doi. 10.1080/00498254.2020.1771795
- By:
- Publication type:
- Article
3
Molecular mechanisms of ethanol biotransformation: enzymes of oxidative and nonoxidative metabolic pathways in human.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1180, doi. 10.1080/00498254.2020.1761571
- By:
- Publication type:
- Article
4
Inhibition of UDP-glucuronosyltransferases by different furoquinoline alkaloids.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1170, doi. 10.1080/00498254.2020.1760400
- By:
- Publication type:
- Article
5
Preference for O-demethylation reactions in the oxidation of 2′-, 3′-, and 4′-methoxyflavones by human cytochrome P450 enzymes.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1158, doi. 10.1080/00498254.2020.1759157
- By:
- Publication type:
- Article
6
Differential changes in the pharmacokinetics of doxorubicin in diethylnitrosamine-induced hepatocarcinoma model rats.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1251, doi. 10.1080/00498254.2020.1765049
- By:
- Publication type:
- Article
7
Prediction of pharmacokinetic clearance and potential Drug-Drug interactions for omeprazole in the horse using in vitro systems.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1220, doi. 10.1080/00498254.2020.1764131
- By:
- Publication type:
- Article
8
Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liver.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1208, doi. 10.1080/00498254.2020.1763513
- By:
- Publication type:
- Article
9
Assessment of in vitro inhibitory effects of novel anti MRSA benzoquinolizine fluoroquinolone WCK 771 (levonadifloxacin) and its metabolite on human liver cytochrome P450 enzymes.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1149, doi. 10.1080/00498254.2020.1756007
- By:
- Publication type:
- Article
10
Is aspirin a substrate of MDR1/P-glycoprotein?
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1258, doi. 10.1080/00498254.2020.1757785
- By:
- Publication type:
- Article
11
Pharmacokinetics of trastuzumab deruxtecan (T-DXd), a novel anti-HER2 antibody-drug conjugate, in HER2-positive tumour-bearing mice.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1242, doi. 10.1080/00498254.2020.1755909
- By:
- Publication type:
- Article
12
Nuclear receptor co-repressor RIP140 regulates diurnal expression of cytochrome P450 2b10 in mouse liver.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1139, doi. 10.1080/00498254.2020.1751342
- By:
- Publication type:
- Article
13
Expression of Concern.
- Published in:
- 2020
- Publication type:
- Correction Notice
14
Pharmacokinetics and tissue disposition of enrofloxacin in rainbow trout after different routes of administration.
- Published in:
- Xenobiotica, 2020, v. 50, n. 10, p. 1236, doi. 10.1080/00498254.2020.1747119
- By:
- Publication type:
- Article